Our guest in this episode is the American entrepreneur, Charles Theuer, who has a long career in clinical research and drug development. He shares with us his analysis on the current trends and the future of oncology drug development. In this episode you can learn why there are less cancer clinical trials during the last years and what are the promising therapeutic classes.

Charles has written 2 books which we also discuss in this episode. One of them, Unnecessary Expense, covers important topics in drug development and the importance of self-management of clinical trials which could be of interest for all small companies but also for industry experts.

His books are available on Amazon below:

Unnecessary Expense: An Antidote for the Billion Dollar Drug Problem -